Trading
Data
Solutions
Insights
About
Reven Pharmaceuticals is a clinical-stage biopharmaceutical company that aims to treat metabolic and vascular diseases. With a mission to target the root cause of disease through innovative pursuits, Reven Pharmaceuticals uses its RJX platform to enhance medicines and improve patient outcomes. They also aim to treat diseases such as endothelial dysfunction, coronary artery disease, critical limb ischemia, and more. Reven Pharmaceuticals was founded by Brian Denomme and Peter Lange in 1999 and is headquartered in Denver, CO.
Reven Pharmaceuticals is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
If you own Reven Pharmaceuticals pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.
Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.
Reven Pharmaceuticals is a private company and not publicly traded.
If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.
